Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন
Indications:
EMPALINA 25/5 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate.
Pharmacology:
This tablet combines two antihyperglycemic agents:
-
Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that reduces glucose reabsorption in the kidneys and increases urinary glucose excretion.
-
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases incretin levels, promoting insulin release and decreasing glucagon levels in a glucose-dependent manner.
Dosage:
The recommended dose is one tablet once daily, taken as directed by a registered physician.
Administration:
EMPALINA 25/5 mg should be taken orally, with or without food, at the same time each day for best results.
Interaction:
May interact with insulin, sulfonylureas, diuretics, ACE inhibitors, and some antibiotics, increasing the risk of hypoglycemia or dehydration.
Contraindications:
-
Type 1 diabetes mellitus
-
Diabetic ketoacidosis
-
Severe renal or hepatic impairment
-
Known hypersensitivity to any component of the drug
Side Effects:
Common side effects may include increased urination, urinary tract infections, headache, dizziness, and hypoglycemia (especially when used with other antidiabetics).
Pregnancy & Lactation:
Use during pregnancy and breastfeeding is not recommended unless clearly necessary. Always consult a physician before use.
Precautions & Warnings:
Monitor renal function before and during treatment. Ensure adequate hydration. Caution is advised in elderly patients or those with cardiovascular risks.
Therapeutic Class:
Combination oral antidiabetic agents (SGLT2 inhibitor + DPP-4 inhibitor)
Storage Conditions:
Store below 30°C in a cool, dry place. Keep out of reach of children.
 100 IU.jpg)
 15050160.jpg)
 350ML.jpg)
 10025 100 MG 25 MG.jpg)
 60 ML.jpg)
 100 IU.jpg)
.jpg)
 20025 20025.jpg)
.jpg)
 350ML.jpg)
 30PCS.jpg)
 400MG.jpg)
Change Language